검색
Collplant Biotechnologies Ltd
CLGN관심 목록에 추가
3.920USD
-0.120-2.97%
시장 운영 시간 09/24, 13:27（ET）
74.13M시가총액
손실P/E TTM
Collplant Biotechnologies Ltd 정보 회사
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Collplant Biotechnologies Ltd 프로필
종목 코드 CLGN
회사 이름Collplant Biotechnologies Ltd
상장일Sep 01, 1993
CEORotem (Eran)
직원 수57
유형Ordinary Share
회계 연도 종료Sep 01
주소4 Oppenheimer Street
도시REHOVOT
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호7670104
전화972732325600
웹사이트https://www.collplant.com
종목 코드 CLGN
상장일Sep 01, 1993
CEORotem (Eran)
Collplant Biotechnologies Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
1.51K
+86.78%
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
1.51K
+86.78%
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
1.51K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
313.00
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
5.61K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
2.63K
--
자주 묻는 질문
Collplant Biotechnologies Ltd의 상위 5대 주주는 누구인가요?
Collplant Biotechnologies Ltd의 상위 5대 주주는 다음과 같습니다: Mr. Yehiel Tal
Collplant Biotechnologies Ltd(CLGN)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Collplant Biotechnologies Ltd의 주식을 보유한 기관은 총 35곳이며, 이들이 보유한 주식의 총 가치는 약 1.89M로 전체 발행 주식의 13.14%를 차지합니다. 이는 2025Q4 대비 -218892.00 증가한 수치입니다.
Collplant Biotechnologies Ltd의 최대 수익원은 무엇인가요?
2026Q1 기준, Collplant Biotechnologies Ltd의 Revenues from licensing agreement 부문이 가장 높은 매출을 기록했으며, 금액은 2.00M로 전체 매출의 84.35%를 차지했습니다.